Langerhans cell histiocytosis diagnosed by FNAC of lymph nodes

Shashikant C U Patne1, Saloni Dwivedi, Richa Katiyar

  • 1Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Insights

Langerhans cell histiocytosis (LCH), a rare dendritic cell disorder, can predominantly affect lymph nodes. Fine-needle aspiration cytology (FNAC) offers a rapid and accurate method for diagnosing this LCH presentation.

Area of Science:

  • Oncology
  • Pediatrics
  • Pathology

Background:

  • Langerhans cell histiocytosis (LCH) is a rare clonal disorder involving dendritic cell proliferation.
  • While bone, skin, and lymph nodes are common sites, LCH with predominant lymph node involvement is infrequently diagnosed via fine-needle aspiration cytology (FNAC).

Observation:

  • A 2-year-old boy presented with generalized lymphadenopathy, fever, cough, hepatosplenomegaly, anemia, and skull lytic lesions.
  • FNAC of a submandibular lymph node revealed features consistent with LCH.
  • Immunostaining on FNAC smears showed positive S-100 protein in LCH cells.

Findings:

  • FNAC demonstrated features of LCH in a pediatric patient with generalized lymphadenopathy.
  • Immunohistochemistry, including S-100 protein and CD1a, confirmed LCH diagnosis on lymph node biopsy.
  • The patient received chemotherapy and is undergoing follow-up.

Implications:

  • This case underscores the diagnostic utility of FNAC for lymph node-predominant LCH.
  • FNAC provides a rapid and accurate preliminary diagnosis, guiding further management.
  • Early diagnosis through FNAC is crucial for timely treatment of LCH.

Related Concept Videos